Peter Zipfel Leibniz Institute for Natural Product Research and Infection BiologyGermany

Peter Zipfel
Peter F. Zipfel, is University-Professor at Friedrich Schiller University, Jena and Department Head at the Leibniz Institute for Natural Product Research and Infection Biology - e in Jena Germany. His research focuses on complement in health and disease, the role of the complement system in HUS and C3 Glomerulopathy, and as target for human pathogenic microbes. Dr. Zipfel has a deep interest in complement factor H, and in Factor H related proteins. Dr. Zipfel received his PhD from the University of Bremen. He was a postdoctoral fellow in the Laboratory for Immunoregulation, National Institutes of Health in Bethesda, Maryland USA headed by Dr. Anthony Fauci. Dr. Zipfel was then Group -eader at Bernhard Nocht Institute for Tropical Medicine Hamburg and Professor at the University of Hamburg. He has organized in 2013 the 14th European Meeting on Complement in Human Diseases and the 28th International Complement workshop in the year 2021.
Institution

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10:30 a.m.
Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico
ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina
  • Updates on IgAN Management
    HernánTrimarchi Speaker htrimarchi@hotmail.comHOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
  • Membranous GN Classification and Management
    PierreRonco Speaker pierreronco@yahoo.frHôpital TenonFrance
  • MPGN Updates
    SanjeevSethi Speaker sethi.sanjeev@mayo.eduMayo ClinicUnited States
  • Managing Vasculitis
    RobertaFenoglio Speaker roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly
  • Q and A
Hall A
12:30 p.m.
1:30 p.m.
AnujaJava Chairperson ajava@wustl.eduWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUISUnited States
Prof LizLightstone Chairperson l.lightstone@imperial.ac.ukImperial College LondonUnited Kingdom
  • Complement in Kidney Disease: Overview of the Complement Cascade in Kidney Injury
    Peter Zipfel Speaker Peter.Zipfel@hki-jena.deLeibniz Institute for Natural Product Research and Infection BiologyGermany
  • C3 Glomerulopathy: New Developments and Therapeutic Targets
    CarlaNester Speaker carla-nester@uiowa.eduUniversity of IowaUnited States
  • Challenges in Diagnosing C3G
    SallyJohnson Speaker sallyajohnson73@gmail.comNational Renal Complement Therapeutics Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, United KingdomUnited Kingdom
  • Q and A
Hall C1